Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Peptinnovate

Peptinnovate?uq=x1rNslWr
2011 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$3.03M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of anti-inflammatory peptides designed to treat immuno-inflammatory diseases resulting from a poorly controlled or overactive immune response. The company's anti-inflammatory peptides have the ability to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for diseases modification and remission, enabling patients with immuno-inflammatory diseases like asthma, atopic dermatitis and inflammatory bowel diseases to get better treatment and faster recovery.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Stevenage Bioscience Catalyst, Gunnels Wood Road
  • Hertfordshire
  • Stevenage SG1 2FX
  • England

+44 01438 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Peptinnovate’s full profile, request a free trial.

Peptinnovate Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 14-Jun-2017 $3.03M 00.000 Completed Startup
3. Early Stage VC 28-Jul-2015 00000 00.000 000.00 Completed Startup
2. Grant $938K Completed Startup
1. Angel (individual) 17-Dec-2014 $938K $938K 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Peptinnovate Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
To view this company’s complete Cap Table, request access »

Peptinnovate Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
NCL Technology Ventures Asset Manager Minority 000 0000 000000 0
Metellus Venture Capital Minority 000 0000 000000 0

Peptinnovate Executive Team (9)

Name Title Board
Seat
Contact
Info
Andrew Lightfoot Ph.D Board Member, Founder & Co-Chief Executive Officer
Richard Nagle Chief Executive Officer & Board Member
Clare Burgess Ph.D Chief Operating Officer
Nicky Cooper Ph.D Co-Chief Scientific Officer
Richard Knowles Co-Chief Scientific Officer
You’re viewing 5 of 9 executives. Get the full list »

Peptinnovate Board Members (7)

Name Representing Role Since Contact
Info
Andrew Lightfoot Ph.D Peptinnovate Board Member, Founder & Co-Chief Executive Officer 000 0000
Anthony Martin Ph.D Peptinnovate Chairman 000 0000
Clive Page Peptinnovate Board Member 000 0000
David Beadle Peptinnovate Chief Business Officer & Board Member 000 0000
Michael Albisser Self Board Member & Chief Financial Officer 000 0000
You’re viewing 5 of 7 board members. Get the full list »